Table 2.
Serum sodium and creatinine by hypernatremia progression status.
| Biochemistry | All Patients n = 180 |
Non-Progressors n = 163 |
Progressors n = 17 |
|---|---|---|---|
| On admission | |||
| Na+, mean (SD), mmol/L | 138 (5) | 138 (5) | 138 (5) |
| Creatinine, mean (SD), µmol/L | 154 (115) | 149 (115) | 193 (113) |
| Creatinine, median (IQR), µmol/L | 123 (85–170) | 120 (80–168) | 194 (112–235) |
| At onset of Na+ 150 mmol/L | |||
| Na+, mean (SD), mmol/L | 152 (3) | 152 (2) | 155 (3) |
| Creatinine, mean (SD), µmol/L | 147 (105) | 145 (106) | 168 (84) |
| Creatinine, median (IQR), µmol/L | 122 (86–171) | 120 (85–170) | 145 (117–206) |
| Time from admission, mean (SD), days | 7.3 (6.7) | 7.2 (6.6) | 7.7 (7.6) |
| At peak of Na+ | |||
| Na+, mean (SD), mmol/L | 155 (4) | 154 (3) | 162 (3) |
| Creatinine, mean (SD), µmol/L | 149 (105) | 144 (105) | 190 (90) |
| Creatinine, median (IQR), µmol/L | 123 (84–174) | 115 (80–163) | 176 (142–219) |
| Time from onset, mean (SD), days | 1.5 (3.0) | 1.1 (2.5) | 4.8 (4.8) |